Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes. (nature.com)

Authors: Lin CL … Wu SY Journal: Nature Communications Published: 2026-08-22 DOI: https://doi.org/10.1038/s41467-026-77047-5